- 24/7 Wall St.•4 days ago
The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. At first 2017 seemed like it could be different for this sector, ...
- GlobeNewswire•5 days agoImmunomedics to Mail Letter to Stockholders Highlighting Unprecedented Progress Toward Enhanced Value Creation
Urges Stockholders to Vote“ FOR” Each of Immunomedics’ Highly-Qualified Director Nominees on the WHITE Proxy Card. venBio Rejects Constructive, Stockholder-Friendly Settlement Proposal and Insists on Unilateral ...
- Business Wire•6 days ago
venBio Select Advisor LLC , the beneficial owner of approximately 9.5 million shares, or 9.0%, of Immunomedics, Inc. and its largest stockholder, today sent a letter to Immunomedics stockholders in connection with venBio’s nomination of four highly-qualified candidates – Scott Canute, Peter Barton Hutt, Dr.
IMMU : Summary for Immunomedics, Inc. - Yahoo Finance
Immunomedics, Inc. (IMMU)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||3.88 - 4.24|
|52 Week Range||1.61 - 5.44|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-6.48|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|